Oregon State researchers, including a member of the College of Science, have shown in a mouse model and lab cultures that a compound derived from hops reduces the abundance of a gut bacterium associated with metabolic syndrome.
A six-month study of healthy older men led by the College of Science’s Tory Hagen and research associate Alexander Michels demonstrated that daily multivitamin/multimineral supplementation had a positive effect on key nutrition biomarkers.
Goldwater scholar and graduating senior Alyssa Pratt has always had a love for the sciences. She started with a love for the stars and now spends her day in the cyberspace realm with her double major in computer science; and biochemistry and molecular biology at Oregon State University.
Being a Beaver has stretched Ebunoluwa Morakinyo to develop her passions inside and outside of the lab. A senior honors biochemistry and molecular biology student at Oregon State, her time on campus has included celebrating her culture while looking forward to a career dedicated to helping others.
Four-dimensional tissue self-assembly, integrated river health and ultra-tiny spectrometers: The 2022 College of Science Research and Innovation Seed (SciRIS) award recipients will use collaboration to fill critical knowledge gaps across numerous scientific disciplines to drive real-world impact.
One question changed the course of Tari Tan’s (Biochemistry & Biophysics, ‘08) professional career.
Honors Biochemistry and Molecular Biology junior Gretchen Fujimura is one of two Oregon State students to receive the 2022 Goldwater Scholarships, the nation’s top undergraduate award for sophomores and juniors in the fields of science, technology, engineering and mathematics.
Seed funding from the College of Science Research and Innovation Seed (SciRIS) program continues to bolster ambitious and expansive research projects across biomedical science, fluid dynamics, quantum mechanics and more.
Congratulations to the following faculty members that have been given awards to support their proposed research!
Researchers from the Department of Biochemistry and Biophysics have discovered a new class of potential drug targets for people suffering from neurodegenerative conditions such as Alzheimer’s, Parkinson’s and Lou Gehrig’s disease.